Campagnoli Monica, Kragh-Hansen Ulrich, Overgaard Pedersen Anders, Amoresano Angela, Lyon Andrew W, Cesati Roberto, Sala Alberto, Romano Assunta, Galliano Monica, Minchiotti Lorenzo
Department of Biochemistry A Castellani, via Taramelli 3b, Università di Pavia, 27100 Pavia, Italy.
Clin Biochem. 2003 Nov;36(8):597-605. doi: 10.1016/s0009-9120(03)00118-8.
To purify and structurally identify two albumin variants found in the Canadian population of native Amerindian origin. To assess the ability of variant albumins to bind lauric acid and L-thyroxine.
The structural characterization of the alloalbumins was performed by conventional protein chemistry methods and by mass spectrometric analysis. Lauric acid and L-thyroxine affinities to variant albumins were assessed by kinetic dialysis and equilibrium dialysis techniques, respectively.
The sequence investigations proved the two variants to be albumin Naskapi [372Lys --> Glu] and albumin Vancouver [501Glu --> Lys], respectively. Among the carriers of albumin Naskapi, we found a rare case of homozygosity. Furthermore, this is the first reported case of the 501Glu-->Lys mutation in the native North American population. Scatchard plot analysis revealed that the association constants for lauric acid and L-thyroxine to the two variants were indistinguishable from the endogenous form of albumin.
We show that albumin variants Vancouver and Naskapi have normal fatty acid and L-thyroxine binding capabilities. These findings support the assumption that bisalbuminemias associated with these albumin variants are benign conditions.
纯化并从结构上鉴定在加拿大美洲印第安人后裔群体中发现的两种白蛋白变体。评估变体白蛋白结合月桂酸和L-甲状腺素的能力。
通过传统蛋白质化学方法和质谱分析对同种白蛋白进行结构表征。分别采用动力学透析和平衡透析技术评估月桂酸和L-甲状腺素与变体白蛋白的亲和力。
序列研究证明这两种变体分别为纳斯卡皮白蛋白[372赖氨酸→谷氨酸]和温哥华白蛋白[501谷氨酸→赖氨酸]。在纳斯卡皮白蛋白携带者中,我们发现了一例罕见的纯合子病例。此外,这是北美原住民群体中首次报道的501谷氨酸→赖氨酸突变病例。斯卡查德图分析显示,月桂酸和L-甲状腺素与这两种变体的结合常数与内源性白蛋白形式无明显差异。
我们表明温哥华和纳斯卡皮白蛋白变体具有正常的脂肪酸和L-甲状腺素结合能力。这些发现支持了与这些白蛋白变体相关的双白蛋白血症为良性病症的假设。